These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP. BMJ; 2021 Jul 14; 374():n1537. PubMed ID: 34261627 [Abstract] [Full Text] [Related]
23. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China. Zhao B, He X, Wu J, Yan S. BMC Cardiovasc Disord; 2020 Jun 10; 20(1):282. PubMed ID: 32522146 [Abstract] [Full Text] [Related]
29. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study. Waheed S, Pollack S, Roth M, Reichek N, Guerci A, Cao JJ. Atherosclerosis; 2016 Dec 19; 255():193-199. PubMed ID: 27693004 [Abstract] [Full Text] [Related]
35. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. Virani SS. Tex Heart Inst J; 2013 Dec 19; 40(3):288-9. PubMed ID: 23914021 [No Abstract] [Full Text] [Related]
36. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? Danninger K, Hoppe UC, Pieringer H. Int J Rheum Dis; 2014 Jul 19; 17(6):606-11. PubMed ID: 24931356 [Abstract] [Full Text] [Related]
37. Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil. Santo K, Santos RD, Girotto AN, Nieri J, Monfardini F, Raupp P, Pereira PM, Berwanger O, Machline-Carrion MJ. J Clin Lipidol; 2024 Jul 19; 18(3):e384-e393. PubMed ID: 38431498 [Abstract] [Full Text] [Related]
39. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators. JACC Cardiovasc Imaging; 2017 Feb 19; 10(2):143-153. PubMed ID: 27665163 [Abstract] [Full Text] [Related]
40. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pate A, Elliott RA, Gkountouras G, Thompson A, Emsley R, van Staa T. Pharmacoepidemiol Drug Saf; 2020 Jun 19; 29(6):644-652. PubMed ID: 32394495 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]